Dabigo 75 Capsule Benefits & Uses
Dabigo 75 Capsule is used to treat the following -
Other Benefits
Dabigo 75 Capsule Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Dabigo 75 Capsule Side Effects
Based on research, the following side effects have been observed when Dabigo 75 Capsule is used -
Moderate
Mild
- Urticaria
- Itching or burning
- Rash
Common
- पेट दर्द
- Gastritis (Read More - How to Cure Bloating in the Stomach: Diet Tips and Home Remedies)
- Nausea or vomiting
- Dyspepsia
- Indigestion (Read More - Home Remedies for Indigestion)
Unknown
Dabigo 75 Capsule Related Warnings
-
Is the use of Dabigo 75 Capsule safe for pregnant women?
It is not known what effect Dabigo will have on pregnant women, because no research work has been carried out on this till date.
Unknown -
Is the use of Dabigo 75 Capsule safe during breastfeeding?
No research work has been carried out till date on effect of Dabigo on breastfeeding women. So it is not known whether taking Dabigo will cause side effects or not.
Unknown -
What is the effect of Dabigo 75 Capsule on the Kidneys?
Dabigo may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Moderate -
What is the effect of Dabigo 75 Capsule on the Liver?
Very few cases of side effects of Dabigo on the liver have been reported.
Mild -
What is the effect of Dabigo 75 Capsule on the Heart?
Dabigo can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Moderate
Severe Interaction of Dabigo 75 Capsule with Other Drugs
Dabigo 75 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Dabigo 75 Capsule Contraindications
If you are suffering from any of the following diseases, you should not take Dabigo 75 Capsule unless your doctor advises you to do so -
- Heart Disease
- Bleeding
Frequently asked Questions about Dabigo 75 Capsule
-
Is this Dabigo 75 Capsule habit forming or addictive?
No, there is no any evidence that Dabigo 75 Capsule is addictive.
No -
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Dabigo 75 Capsule as it does not make you drowsy.
Safe -
Is it safe?
Yes, Dabigo 75 Capsule is safe but you must consult your doctor before taking it.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
No, Dabigo 75 Capsule cannot treat any kind of mental disorder.
No
Dabigo 75 Capsule Interactions with Food and Alcohol
-
Interaction between Food and Dabigo 75 Capsule
Some foods when eaten with Dabigo 75 Capsule can alter the onset of actions. Discuss this with your doctor.
Mild -
Interaction between Alcohol and Dabigo 75 Capsule
It is difficult to say anything about the effect of Dabigo 75 Capsule and alcohol. No research has been done on this yet.
Unknown
See all substitutes for Dabigo
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 385
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 623-624
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pradaxa® (dabigatran etexilate mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 385
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 623-624
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pradaxa® (dabigatran etexilate mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 385
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 623-624
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pradaxa® (dabigatran etexilate mesylate)